Literature DB >> 14769149

Association of endogenous G-CSF with anti-inflammatory mediators in patients with acute respiratory distress syndrome.

Franz J Wiedermann1, Andreas J Mayr, Petra Hobisch-Hagen, Dietmar Fuchs, Wolfgang Schobersberger.   

Abstract

Upregulation of the anti-inflammatory mediators, soluble tumor necrosis factor-alpha receptors I and II (sTNFRI/RII) and interleukin-1 receptor antagonist (IL-1RA), by granulocyte colony-stimulating factor (G-CSF) may contribute to the pathophysiology of lung injury. We determined the relation of endogenous G-CSF to proinflammatory and anti-inflammatory mediators in bronchoalveolar lavage fluid (BALF) and serum of patients with acute respiratory distress syndrome (ARDS) and acute lung injury (ALI). Nineteen patients with ARDS and 10 with ALI were included in this prospective investigation. BAL was performed within 12 h and 24 h after onset of lung injury. Concentrations of G-CSF, TNF-alpha, IL-6, sTNFRI and sTNFRII, IL-1RA and IL-10 in BALF as well as in serum were determined by ELISA. G-CSF was associated with alveolar neutrophilia. Results in patients with ARDS and ALI exhibited significant positive correlations in BALF of G-CSF levels with that of IL-6, sTNFRII, and IL-1RA and of G-CSF levels in serum with that of serum IL-6, IL-1RA, and IL-10. Given the potential of G-CSF to directly induce anti-inflammatory cytokines in vitro, significant associations of endogenous G-CSF levels with these mediators early in the development of severe lung injury suggest an endogenous anti-inflammatory role of G-CSF in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14769149     DOI: 10.1089/107999003772084842

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  11 in total

1.  Genetic and pharmacologic evidence links oxidative stress to ventilator-induced lung injury in mice.

Authors:  Srinivas Papaiahgari; Adi Yerrapureddy; Swetha R Reddy; Narsa M Reddy; Jeffery M Dodd-O; Michael T Crow; Dimitry N Grigoryev; Kathleen Barnes; Rubin M Tuder; Masayuki Yamamoto; Thomas W Kensler; Shyam Biswal; Wayne Mitzner; Paul M Hassoun; Sekhar P Reddy
Journal:  Am J Respir Crit Care Med       Date:  2007-09-27       Impact factor: 21.405

2.  Polymorphonuclear leucocytes selectively produce anti-inflammatory interleukin-1 receptor antagonist and chemokines, but fail to produce pro-inflammatory mediators.

Authors:  Anja K Schröder; Maren von der Ohe; Ute Kolling; Julia Altstaedt; Peter Uciechowski; Daniela Fleischer; Klaus Dalhoff; Xinsheng Ju; Martin Zenke; Nicole Heussen; Lothar Rink
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

3.  Cholangiocellular carcinoma that produced both granulocyte-colony-stimulating factor and parathyroid hormone-related protein.

Authors:  Tetsuro Sohda; Hiroshi Shiga; Hidetoshi Nakane; Hiroshi Watanabe; Morishige Takeshita; Shotaro Sakisaka
Journal:  Int J Clin Oncol       Date:  2006-06       Impact factor: 3.402

Review 4.  The apoptotic pathway as a therapeutic target in sepsis.

Authors:  Doreen E Wesche-Soldato; Ryan Z Swan; Chun-Shiang Chung; Alfred Ayala
Journal:  Curr Drug Targets       Date:  2007-04       Impact factor: 3.465

5.  Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies.

Authors:  Chin Kook Rhee; Ji Young Kang; Yong Hyun Kim; Jin Woo Kim; Hyung Kyu Yoon; Seok Chan Kim; Soon Suk Kwon; Young Kyoon Kim; Kwan Hyung Kim; Hwa Sik Moon; Sung Hak Park; Hee Je Kim; Seok Lee; Jeong Sup Song
Journal:  Crit Care       Date:  2009-11-03       Impact factor: 9.097

6.  Fatal Interstitial Pneumonitis Rapidly Developed after the First Cycle of CHOP with Etoposide Combination Chemotherapy in a Patient with Lymphoma.

Authors:  Hyung Chul Park; Jae-Sook Ahn; Deok-Hwan Yang; Sung-Hoon Jung; In-Jae Oh; Song Choi; Seung-Shin Lee; Mi-Young Kim; Yeo-Kyeoung Kim; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-05-31

7.  Keratinocyte growth factor promotes epithelial survival and resolution in a human model of lung injury.

Authors:  Murali Shyamsundar; Daniel F McAuley; Rebecca J Ingram; David S Gibson; Donal O'Kane; Scott T McKeown; Alex Edwards; Cliff Taggart; Joseph S Elborn; Carolyn S Calfee; Michael A Matthay; Cecilia M O'Kane
Journal:  Am J Respir Crit Care Med       Date:  2014-06-15       Impact factor: 21.405

8.  Effects of early administration of a novel anticholinergic drug on acute respiratory distress syndrome induced by sepsis.

Authors:  Hao Li; Zhaoxin Qian; Jianmin Li; Xiaotong Han; Min Liu
Journal:  Med Sci Monit       Date:  2011-11

9.  Granulocyte colony stimulating factor attenuates hyperoxia-induced lung injury by down-modulating inflammatory responses in neonatal rats.

Authors:  Ga Won Jeon; Dong Kyung Sung; Yu Jin Jung; Soo Hyun Koo; Seo Heui Choi; Yun Sil Chang; Jong Beom Sin; Won Soon Park
Journal:  Yonsei Med J       Date:  2011-01       Impact factor: 2.759

10.  Respiratory status deterioration during G-CSF-induced neutropenia recovery.

Authors:  L Karlin; M Darmon; G Thiéry; M Ciroldi; S de Miranda; A Lefebvre; B Schlemmer; E Azoulay
Journal:  Bone Marrow Transplant       Date:  2005-08       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.